Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEWTARGET real-world PK and TDM-guided dosing study
jRCT1011240022Recruiting
- Sponsor
- Sapporo Medical University Hospital
- Start
- Jul 2024
- Countries
- 1
01
Overview
Open-label, single-arm trial in Neoplasm, bronchial carcinoma, inflammatory bowel disease (IBD) and 2 more, sponsored by Sapporo Medical University Hospital. Primary endpoint: Variability of pharmacokinetics. Started Jul 2024; status: recruiting.
02
Conditions
Neoplasmbronchial carcinomainflammatory bowel disease (IBD)rheumatoid arthritis (RA)autoimmune disease
Beyond the preview
Go deeper on jRCT1011240022.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1011240022.